Goldman Sachs’s Asensus Surgical, Inc. ASXC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-10,892
| Closed | -$5.5K | – | 5936 |
|
|
2023
Q2 | $5.5K | Sell |
10,892
-26,134
| -71% | -$15.6K | ﹤0.01% | 5623 |
|
|
2023
Q1 | $24.4K | Buy |
37,026
+26,601
| +255% | +$18K | ﹤0.01% | 5646 |
|
|
2022
Q4 | $3.62K | Sell |
10,425
-23,797
| -70% | -$9.67K | ﹤0.01% | 5835 |
|
|
2022
Q3 | $15K | Sell |
34,222
-89,240
| -72% | -$46.5K | ﹤0.01% | 5987 |
|
|
2022
Q2 | $49K | Sell |
123,462
-87,275
| -41% | -$38.9K | ﹤0.01% | 6031 |
|
|
2022
Q1 | $133K | Buy |
210,737
+85,487
| +68% | +$65.9K | ﹤0.01% | 6017 |
|
|
2021
Q4 | $139K | Sell |
125,250
-87,523
| -41% | -$135K | ﹤0.01% | 6027 |
|
|
2021
Q3 | $393K | Sell |
212,773
-53,997
| -20% | -$121K | ﹤0.01% | 5345 |
|
|
2021
Q2 | $846K | Sell |
266,770
-38,155
| -13% | -$95.4K | ﹤0.01% | 4885 |
|
|
2021
Q1 | $991K | Buy |
+304,925
| New | +$1.1M | ﹤0.01% | 4625 |
|
|
2020
Q3 | – | Sell |
-38,831
| Closed | -$21K | – | 5578 |
|
|
2020
Q2 | $21K | Buy |
38,831
+4,693
| +14% | +$2.27K | ﹤0.01% | 5125 |
|
|
2020
Q1 | $12K | Sell |
34,138
-5,490
| -14% | -$5.73K | ﹤0.01% | 5157 |
|
|
2019
Q4 | $58K | Buy |
39,628
+27,987
| +240% | +$97.2K | ﹤0.01% | 5107 |
|
|
2019
Q3 | $94K | Buy |
11,641
+1,190
| +11% | +$16.2K | ﹤0.01% | 4973 |
|
|
2019
Q2 | $185K | Buy |
10,451
+2,622
| +33% | +$57.4K | ﹤0.01% | 4817 |
|
|
2019
Q1 | $242K | Sell |
7,829
-13,363
| -63% | -$448K | ﹤0.01% | 4721 |
|
|
2018
Q4 | $622K | Sell |
21,192
-17,432
| -45% | -$792K | ﹤0.01% | 4244 |
|
|
2018
Q3 | $2.91M | Sell |
38,624
-31,123
| -45% | -$2.11M | ﹤0.01% | 3342 |
|
|
2018
Q2 | $3.95M | Sell |
69,747
-4,381
| -6% | -$160K | ﹤0.01% | 3124 |
|
|
2018
Q1 | $1.64M | Buy |
74,128
+72,778
| +5,391% | +$1.67M | ﹤0.01% | 3729 |
|
|
2017
Q4 | $34K | Sell |
1,350
-11,062
| -89% | -$340K | ﹤0.01% | 6024 |
|
|
2017
Q3 | $231K | Sell |
12,412
-80,142
| -87% | -$932K | ﹤0.01% | 5667 |
|
|
2017
Q2 | $854K | Buy |
92,554
+91,275
| +7,136% | +$868K | ﹤0.01% | 4609 |
|
|
2017
Q1 | $20K | Sell |
1,279
-3,127
| -71% | -$54.2K | ﹤0.01% | 6520 |
|
|
2016
Q4 | $74K | Sell |
4,406
-7,926
| -64% | -$162K | ﹤0.01% | 6271 |
|
|
2016
Q3 | $271K | Sell |
12,332
-9,213
| -43% | -$168K | ﹤0.01% | 5561 |
|
|
2016
Q2 | $342K | Sell |
21,545
-14,394
| -40% | -$452K | ﹤0.01% | 5231 |
|
|
2016
Q1 | $1.99M | Sell |
35,939
-27,542
| -43% | -$1.18M | ﹤0.01% | 3473 |
|
|
2015
Q4 | $2.05M | Buy |
63,481
+21,352
| +51% | +$688K | ﹤0.01% | 3604 |
|
|
2015
Q3 | $1.24M | Buy |
42,129
+40,538
| +2,548% | +$1.5M | ﹤0.01% | 4262 |
|
|
2015
Q2 | $62K | Buy |
+1,591
| New | +$73.3K | ﹤0.01% | 6807 |
|
|
2015
Q1 | – | Sell |
-1,790
| Closed | -$68K | – | 7329 |
|
|
2014
Q4 | $68K | Buy |
+1,790
| New | +$73.9K | ﹤0.01% | 6718 |
|
|
2014
Q3 | – | Sell |
-1,578
| Closed | -$103K | – | 7300 |
|
|
2014
Q2 | $103K | Buy |
+1,578
| New | +$91.1K | ﹤0.01% | 6537 |
|
Other funds holding ASXC
MCM
AA
Goldman Sachs's ASXC Position: Q3 2023 in Review
Goldman Sachs sold out of Asensus Surgical, Inc. (ASXC) in Q3 2023, closing a stake of 10,892 shares — an estimated $5.5K sold.
Goldman Sachs first reported a position in ASXC in Q2 2014 and held it in 33 quarters. The position peaked at $3.95M in Q2 2018. 68 funds tracked by Wall St. Rank hold ASXC as of Q3 2023.
- Goldman Sachs reported no remaining Asensus Surgical, Inc. position as of Q3 2023 after selling out during the quarter.
- Goldman Sachs sold 10,892 Asensus Surgical, Inc. shares in Q3 2023, an estimated $5.5K.
- Goldman Sachs first reported a position in Asensus Surgical, Inc. in Q2 2014 and held it in 33 quarters.
- Goldman Sachs's Asensus Surgical, Inc. position peaked at $3.95M in Q2 2018.
- 68 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q3 2023.
Based on Goldman Sachs's 13F filing for Q3 2023, filed 14 Nov 2023.